FDA.reportPublic FDA data

roflumilast 0.15 % Topical Cream

RxCUI
2687710
RxNorm name
roflumilast 0.15 % Topical Cream
Display name
roflumilast 0.15 % Topical Cream
Full name
roflumilast 0.15 % Topical Cream
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZORYVEROFLUMILASTArcutis Biotherapeutics, Inc.ec1bb0d1-f38a-4080-831a-68791d1d1fdb2026-07-20Adverse reactionsExact identifier
rxcui: 2687710

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ec1bb0d1-f38a-4080-831a-68791d1d1fdbroflumilast 0.15 % Topical Cream [PSN] · roflumilast 1.5 MG/ML Topical Cream [SCD] · roflumilast 0.15 % Topical Cream [SY]312These highlights do not include all the information needed to use ZORYVE cream safely and effectively. See full prescribing information for ZORYVE cream. ZORYVE ® (roflumilast) cream 0.3%, 0.15%, 0.05%, for topical use Initial U.S. Approval: 201120260130